Robichaud Albert 4
4 · Sage Therapeutics, Inc. · Filed Feb 14, 2020
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-12+20,000→ 20,000 totalExercise: $68.87Exp: 2030-02-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The securities awarded on February 12, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock shall vest on the one year anniversary of February 12, 2020, with 15,000 shares vesting in 36 equal monthly installments thereafter.